Valter Niemelä
Specialistläkare vid Institutionen för medicinska vetenskaper; Neurologi
- E-post:
- valter.niemela@neuro.uu.se
- Besöksadress:
- Akademiska sjukhuset
- Postadress:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
- Akademiska meriter:
- Med. dr.
- ORCID:
- 0000-0002-2576-9938
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Jag arbetar som neurolog med inriktning mot neurogenetiska sjukdomar och disputerade 2019 med en avhandling om biomarkörer i ryggmärgsvätska vid Huntingtons sjukdom. Jag försöker hitta synergier mellan kliniskt arbetssätt och insamlandet av data för forskning för att förbättra vård och behandling vid neurogenetiska sjukdomar.
Nyckelord
- genetik
- inflammation
- neurobiologi
- neurologi
- neuropsykiatriska funktionsnedsättningar
Biografi
Läkarexamen 2012
Medicine doktor (PhD) 2019.
Specialistläkare Neurologi 2020.
Post-doc tjänst 33% start 2022.
Forskning
Läs mer på forskargruppens hemsida:
Media
Denna text finns inte på svenska, därför visas den engelska versionen.
On Chorea, George Huntington
En film skapad av professor Aquilonius föreställande George Huntington
http://play.quickchannel.com/Qc/create/mainshow.asp?play=6790
Publikationer
Senaste publikationer
- Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease (2024)
- Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases (2023)
- Case report (2023)
- Genetic screening for Huntington disease phenocopies in Sweden (2023)
- Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus (2022)
Alla publikationer
Artiklar
- Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease (2024)
- Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases (2023)
- Case report (2023)
- Genetic screening for Huntington disease phenocopies in Sweden (2023)
- Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus (2022)
- Sjukdomsmarkörer för Huntingtons sjukdom (2021)
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease (2021)
- Aniridia with PAX6 mutations and narcolepsy (2020)
- Huntingtons sjukdom – kliniska prövningar inger nu optimism (2020)
- Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations (2020)
- High frequency of intermediary alleles in the HTT gene in Northern Sweden (2020)
- Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease (2019)
- Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects (2019)
- Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease (2018)
- Cognitive decline in Huntington’s disease expansion gene carriers (2017)
- Narcolepsy as a side effect of swine flu vaccination (2017)
- Tau or neurofilament light - Which is the more suitable biomarker for Huntington’s disease? (2017)
- Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate (2014)
Böcker
